Infinium Global Research Cancer Therapeutics and Supportive Care Drugs Mark | Page 2

A latest report has been added to the wide database of Cancer Therapeutics and Supportive Care Drugs Market by Infinium
Global Research. This report studies the Cancer Therapeutics and Supportive Care Drugs Market by type (cancer
therapeutics, supportive care drugs), by distribution channel (hospital, retail) market status and outlook of global and major
regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments
& countries in recent years and to forecast the values for the next six years. Cancer Therapeutics and Supportive Care Drugs
Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive
landscape, latest trends, and product offerings of the major companies in the Cancer Therapeutics and Supportive Care Drugs
Market. According to the report the Global Cancer Therapeutics and Supportive Care Drugs Market is projected to grow at a
CAGR of 9.7% in terms of value over the period of 2017-2023.
The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to
this market. New treatment options have become available in the past five years, and the surge of innovation is expected to
continue due to a robust pipeline of drugs in clinical development by a large and diverse group of pharmaceutical companies.
Innovations in the development of new drugs and therapies, large number of new drugs entering into the market with FDA
approval, increasing prevalence of cancerous patients, availability of new treatment options in the market and rise in base of
aging population are the key driving factors for the growth of this market. In addition, changing lifestyle habits of
populations, increased patient’s healthcare awareness, and increasing demand for non-invasive therapies are further
expected to propel the market growth in the coming years. Along with these driving factors, the market for cancer
therapeutics is facing some challenges such as time consuming regulatory compliance and high cost of cancer drugs.
However, the market for cancer therapeutics and supportive care drugs is likely to rise in the future due to the large number
of ongoing innovations for the treatment of cancer.
Geographically, North America is the leading contributor to the market and is expected to retain its position during the
forecast period due to high awareness, presence of large base of cancer patients, rise in investments, and various initiatives
by government in the healthcare sector. However, Asia-Pacific market is expected to grow at a faster rate during the forecast
period. This is predominantly due to increased healthcare awareness, technological advancements, significant investments
and growing awareness among the population about the treatment options available in the market.
Infinium Global Research